Chicharros USA - bolsa internacional

Rebote en ONCS.....+10%

ONCS +13,57%....

Hoy, ONCS +13%.....buen rebote, de momento.....

Atentos a NYBD esta próxima semana, cambio de nombre y símbolo esperado para el lunes/martes.

INNV y NIMU, ayer subieron con fuerza, un 35-40%....
Ambas están en la parte baja del canal lateral y parece que quieren ir a buscar la parte alta otra vez, que en el caso de NIMU es un +100% y en el de INNV un +200%....
A ver si hoy continuan la senda alcista y las liquido con interesantes plus....

Un saludo

ISCO

Venta al CEO de la empresa de más de 4 millones de acciones a 0,09. Supongo que hará suelo ahí.

On September 10, 2014, to obtain funding for working capital purposes, International Stem Cell Corporation (the "Company") entered into a Securities Purchase Agreement (the "Purchase Agreement") with Dr. Andrey Semechkin and Dr. Ruslan Semechkin to sell a total of 4,444,445 shares of common stock at a price of $0.09 per share, for a total purchase price of $400,000. Dr. Andrey Semechkin is the Company's Co-Chairman and Chief Executive Officer. Dr. Ruslan Semechkin is the Company's Chief Scientific Officer and a director. The sale of the shares of common stock was completed on September 10, 2014.

The shares were offered and sold to the purchasers in a private placement transaction made in reliance upon exemptions from registration pursuant to
Section 4(a)(2) under the Securities Act of 1933 and Rule 506 promulgated thereunder. Each purchaser is an accredited investor as defined in Rule 501 of Regulation D promulgated under the Securities Act of 1933.

ISCO

Espera recibir aprobación para inicio de ensayo de parkinson en Australia en febrero.

http://www.utsandiego.com/news/2015/jan/14/parkinsons-stem-cell-parthenogenetic/

han visto MCP
Yactibvos a vaor de ibros vaen mucho mas que acciones y acaban de firmar mionario contrato con siemenns
57 millons de acciones en corto